All stock lists
Sagimet Biosciences Inc. (NASDAQ:SGMT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
9.50-0.08 (-0.79%)
Insider Score
––Not scored
SGMT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
SGMT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 4.28 M | 4.72 M | 4.03 M | 4.60 M | 4.68 M | 4.52 M |
| R&D Expense | 11.54 M | 7.00 M | 6.73 M | 9.73 M | 7.25 M | 15.34 M |
| Operating Expenses | 15.82 M | 11.71 M | 10.77 M | 14.33 M | 11.93 M | 19.86 M |
| Operating Income | -15.82 M | -11.71 M | -10.77 M | -14.33 M | -11.93 M | -19.86 M |
| Pretax Income | -13.95 M | -10.65 M | -9.57 M | -12.91 M | -10.39 M | -18.18 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -13.95 M | -10.65 M | -9.57 M | -12.91 M | -10.39 M | -18.18 M |
| EPS (Basic) | -0.26 | -0.33 | -0.29 | -0.40 | -0.32 | -0.56 |
| EPS (Diluted) | -0.26 | -0.33 | -0.29 | -0.40 | -0.32 | -0.56 |
| Shares Outstanding | 53.11 M | 32.56 M | 32.52 M | 32.46 M | 32.20 M | 32.20 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.